Dr. Michael Borrie

Michael Borrie, MB ChB, FRCPC is a Geriatrician and Professor in the Department of Medicine, Division of Geriatric Medicine, The University of Western Ontario.   

He is the Medical Director for the Aging Brain and Memory Clinic, and an investigator with the Cognitive Clinical Research Group (CCRG).

His research interests include investigator-initiated studies for predictors of conversion from mild cognitive impairment (MCI) to Alzheimer Disease (AD), including sensitive neuroimaging techniques, blood and cerebral spinal fluid biomarkers. He is the platform lead for the Comprehensive Assessment of Neurodegeneration and Aging (COMPASS-ND) observational study of the Canadian Collaboration on Neurodegeneration in Aging (CCNA).

Since 1995 the CCRG has been a leading Canadian research site conducting randomized controlled trials of new potential treatments for Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease.

Maggie Scanlon

Maggie Scanlon is the Director of Programs and Services with the Alzheimer Society Southwest Partners, where she provides strategic leadership for evidence-informed, community-based dementia programs. With over nine years at the Alzheimer Society, Maggie has held progressive roles in public education, volunteer engagement, therapeutic recreation, and provincial program management.

Her work is grounded in advancing inclusive, dementia-friendly communities that support autonomy, participation, and quality of life for people living with dementia and their care partners. Maggie is passionate about fostering environments where individuals can remain active, engaged, and supported to live well with dementia throughout their community.